• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微卫星不稳定型结肠癌中TGFBR2的突变失活源于基因组不稳定与转化生长因子β抗性细胞的克隆性增殖共同作用。

Mutational inactivation of TGFBR2 in microsatellite unstable colon cancer arises from the cooperation of genomic instability and the clonal outgrowth of transforming growth factor beta resistant cells.

作者信息

Biswas Swati, Trobridge Patricia, Romero-Gallo Judith, Billheimer Dean, Myeroff Lois L, Willson James K V, Markowitz Sanford D, Grady William M

机构信息

Department of Medicine, Vanderbilt University Medical School, Nashville, TN, USA.

出版信息

Genes Chromosomes Cancer. 2008 Feb;47(2):95-106. doi: 10.1002/gcc.20511.

DOI:10.1002/gcc.20511
PMID:17985359
Abstract

The mutational inactivation of transforming growth factor beta receptor type II (TGFBR2) occurs in approximately 30% of colon cancers and promotes the formation of colon cancer by inhibiting the tumor suppressor activity of the TGFB signaling pathway. TGFBR2 mutations occur in >90% of microsatellite unstable (MSI) colon cancers and affect a polyadenine tract in exon 3 of TGFBR2, called BAT-RII, which is vulnerable to mutation in the setting of DNA mismatch repair (MMR) system deficiency. In light of the vulnerable nature of the BAT-RII tract in the setting of MMR inactivation and the favorable effects of TGFBR2 inactivation in colon cancer, analysis of TGFBR2 inactivation provides an opportunity to assess the roles of genomic instability vs. clonal selection in cells acquiring TGFBR2 BAT-RII tract mutations in MSI colon cancer formation. The contribution of genomic instability and/or clonal evolution to the mutational inactivation of TGBFR2 in MSI colon cancers has not been studied in a systematic way that would allow a determination of the relative contribution of these two mechanisms in the formation of MSI colon cancer. It has not been demonstrated whether the BAT-RII tract mutations are strictly a consequence of the BAT-RII region being hypermutable in the setting of MMR deficiency or if the mutations are rather a consequence of clonal selection pressure against the TGFB receptor. Through the use of defined cell line systems, we show that both genomic instability and clonal selection of TGFB resistant cells contribute to the high frequency of TGFBR2 mutations in MSI colon cancer.

摘要

约30%的结肠癌中会发生转化生长因子βII型受体(TGFBR2)的突变失活,其通过抑制TGFβ信号通路的肿瘤抑制活性来促进结肠癌的形成。TGFBR2突变发生在>90%的微卫星不稳定(MSI)结肠癌中,并影响TGFBR2外显子3中的一个多聚腺嘌呤序列,称为BAT-RII,在DNA错配修复(MMR)系统缺陷的情况下,该序列易发生突变。鉴于在MMR失活情况下BAT-RII序列的易突变性质以及TGFBR2失活对结肠癌的有利影响,对TGFBR2失活的分析为评估基因组不稳定性与克隆选择在MSI结肠癌形成过程中获得TGFBR2 BAT-RII序列突变的细胞中的作用提供了一个机会。基因组不稳定性和/或克隆进化对MSI结肠癌中TGBFR2突变失活的贡献尚未得到系统研究,从而无法确定这两种机制在MSI结肠癌形成中的相对贡献。尚未证实BAT-RII序列突变是否严格是MMR缺陷情况下BAT-RII区域高突变的结果,或者这些突变是否更是针对TGFB受体的克隆选择压力的结果。通过使用特定的细胞系系统,我们表明基因组不稳定性和TGFB抗性细胞的克隆选择都导致了MSI结肠癌中TGFBR2突变的高频率发生。

相似文献

1
Mutational inactivation of TGFBR2 in microsatellite unstable colon cancer arises from the cooperation of genomic instability and the clonal outgrowth of transforming growth factor beta resistant cells.微卫星不稳定型结肠癌中TGFBR2的突变失活源于基因组不稳定与转化生长因子β抗性细胞的克隆性增殖共同作用。
Genes Chromosomes Cancer. 2008 Feb;47(2):95-106. doi: 10.1002/gcc.20511.
2
Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers.微卫星稳定型结肠癌中转化生长因子βⅡ型受体的突变失活
Cancer Res. 1999 Jan 15;59(2):320-4.
3
Transforming growth factor beta receptor type II inactivation promotes the establishment and progression of colon cancer.转化生长因子βⅡ型受体失活促进结肠癌的发生和发展。
Cancer Res. 2004 Jul 15;64(14):4687-92. doi: 10.1158/0008-5472.CAN-03-3255.
4
Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation.转化生长因子βⅡ型受体失活诱导由Apc突变引发的肠道肿瘤发生恶性转化。
Cancer Res. 2006 Oct 15;66(20):9837-44. doi: 10.1158/0008-5472.CAN-06-0890.
5
Proliferation and Cdk4 expression in microsatellite unstable colon cancers with TGFBR2 mutations.伴有TGFBR2突变的微卫星不稳定型结肠癌中的增殖及Cdk4表达
Int J Cancer. 2006 Feb 1;118(3):600-8. doi: 10.1002/ijc.21399.
6
Mutation analysis of the transforming growth factor-beta type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-beta.对抵抗转化生长因子-β抑制生长作用的人细胞系中转化生长因子-βⅡ型受体的突变分析
Oncogene. 1997 Jul 3;15(1):117-22. doi: 10.1038/sj.onc.1201166.
7
Compensation of loss of protein function in microsatellite-unstable colon cancer cells (HCT116): a gene-dependent effect on the cell surface glycan profile.微卫星不稳定结肠癌细胞(HCT116)中蛋白质功能丧失的补偿:对细胞表面聚糖谱的基因依赖性影响。
Glycobiology. 2009 Jul;19(7):726-34. doi: 10.1093/glycob/cwp040. Epub 2009 Mar 17.
8
Mutation analysis of coding sequences of the entire transforming growth factor beta type II receptor gene in sporadic human colon cancer using genomic DNA and intron primers.使用基因组DNA和内含子引物对散发性人类结肠癌中整个转化生长因子β II型受体基因的编码序列进行突变分析。
Oncogene. 1997 Mar 13;14(10):1255-8. doi: 10.1038/sj.onc.1200938.
9
Mutational analysis of the transforming growth factor beta receptor type II gene in hereditary nonpolyposis colorectal cancer and early-onset colorectal cancer patients.遗传性非息肉病性结直肠癌和早发性结直肠癌患者中转化生长因子βⅡ型受体基因的突变分析
Clin Cancer Res. 2000 Feb;6(2):536-40.
10
Activin type II receptor restoration in ACVR2-deficient colon cancer cells induces transforming growth factor-beta response pathway genes.在缺乏激活素受体2型(ACVR2)的结肠癌细胞中恢复激活素II型受体可诱导转化生长因子-β反应途径基因。
Cancer Res. 2004 Nov 1;64(21):7690-6. doi: 10.1158/0008-5472.CAN-04-2082.

引用本文的文献

1
CellNEST reveals cell-cell relay networks using attention mechanisms on spatial transcriptomics.CellNEST利用空间转录组学中的注意力机制揭示细胞间中继网络。
Nat Methods. 2025 Jun 6. doi: 10.1038/s41592-025-02721-3.
2
TGFβ in Pancreas and Colorectal Cancer: Opportunities to Overcome Therapeutic Resistance.TGFβ 在胰腺癌和结直肠癌中的作用:克服治疗抵抗的机会。
Clin Cancer Res. 2024 Sep 3;30(17):3676-3687. doi: 10.1158/1078-0432.CCR-24-0468.
3
A Novel Defined Super-Enhancer Associated Gene Signature to Predict Prognosis in Patients With Diffuse Large B-Cell Lymphoma.
一种用于预测弥漫性大B细胞淋巴瘤患者预后的新型定义的超级增强子相关基因特征。
Front Genet. 2022 Jun 14;13:827840. doi: 10.3389/fgene.2022.827840. eCollection 2022.
4
Loss of MMR and TGFBR2 Increases the Susceptibility to Microbiota-Dependent Inflammation-Associated Colon Cancer.MMR 和 TGFBR2 的缺失增加了对微生物群依赖性炎症相关结直肠癌的易感性。
Cell Mol Gastroenterol Hepatol. 2022;14(3):693-717. doi: 10.1016/j.jcmgh.2022.05.010. Epub 2022 Jun 7.
5
2-Pyridin-4-yl-methylene-beta-boswellic Acid-A Potential Candidate for Targeting O-Methylguanine-DNA Methyltransferase Epi-transcriptional Reprogramming in KRAS G13D-Microsatellite Stable, G12V-Microsatellite Instable Mutant Colon Cancer.2-吡啶-4-基亚甲基-β-乳香酸——一种靶向O-甲基鸟嘌呤-DNA甲基转移酶进行KRAS G13D微卫星稳定、G12V微卫星不稳定突变型结肠癌表观转录重编程的潜在候选物
ACS Pharmacol Transl Sci. 2022 Apr 18;5(5):306-320. doi: 10.1021/acsptsci.1c00228. eCollection 2022 May 13.
6
Therapeutic Targets in Diffuse Midline Gliomas-An Emerging Landscape.弥漫性中线胶质瘤的治疗靶点——新进展
Cancers (Basel). 2021 Dec 13;13(24):6251. doi: 10.3390/cancers13246251.
7
Genetic variation of as a protective genotype for the development of colorectal cancer in men.作为男性结直肠癌发生的一种保护性基因型的基因变异。
World J Gastrointest Oncol. 2021 Nov 15;13(11):1766-1780. doi: 10.4251/wjgo.v13.i11.1766.
8
SMAD4 is critical in suppression of BRAF-V600E serrated tumorigenesis.SMAD4 在抑制 BRAF-V600E 锯齿状肿瘤发生中起关键作用。
Oncogene. 2021 Oct;40(41):6034-6048. doi: 10.1038/s41388-021-01997-x. Epub 2021 Aug 27.
9
TGFB1 polymorphisms and TGF-β1 plasma levels identify gastric adenocarcinoma patients with lower survival rate and disseminated disease.TGFB1 多态性和 TGF-β1 血浆水平可识别生存率较低和疾病扩散的胃腺癌患者。
J Cell Mol Med. 2021 Jan;25(2):774-783. doi: 10.1111/jcmm.16131. Epub 2020 Dec 4.
10
RAD51 Inhibitor Reverses Etoposide-Induced Genomic Toxicity and Instability in Esophageal Adenocarcinoma Cells.RAD51抑制剂可逆转依托泊苷诱导的食管腺癌细胞基因组毒性和不稳定性。
Arch Clin Toxicol (Middlet). 2020;2(1):3-9. doi: 10.46439/toxicology.2.006.